CLINICAL_TRIALS
trial_result
· 2015-11-17
Clinical Trial Update: Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers [Phase 1]
Summary
Phase 1 study evaluating relative bioavailability and bioequivalence of different formulations of opicapone in healthy volunteers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Parkinson | Phase 1 | Status: COMPLETED | Results posted: 2015-11-17